Proactiveinvestors Interviews Bob Proulx

Proactiveinvestors Interviews Bob Proulx

Proactiveinvestors news media have interviewed Imagion Biosystems CEO Bob Proulx, who answers questions about the company’s early cancer detection technology, its place in the the medical imaging market, intellectual property protections, and more.

Imagion Biosytems Pioneering Medical Imaging with “Printer and Ink” Business Model

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.